Preclinical studies and clinical experience with parathyroid hormone and its analogues

Current Opinion in Orthopaedics

Volumn 9, Issue 5, 1998, Pages 1-6

  Gasser, Juerg A ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; ESTROGEN RECEPTOR; PARATHYROID HORMONE; PARATHYROID HORMONE DERIVATIVE;

ARTICLE; BONE ATROPHY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG STRUCTURE; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; PULSATILE DRUG RELEASE;

EID: 0032411103     PISSN: 10419918     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001433-199810000-00001     Document Type: Article

References (32)

1. Gasser JA, Jerome CP: Parathyroid hormone: a cure for osteoporosis? Triangle 1992, 31:111-121.
2. Dempster DW, Cosman F, Parisien M, Shen V, Lindsay R: Anabolic actions of parathyroid hormone on bone. Endocr Rev 1993, 14:690-709.
3. Gasser JA: PTH peptides and other anabolic agents. In Proceedings of the 1st International Seminar on Advances in Osteoporosis, Athens, 10-11 May 1997, vol 1. Edited by Lyritis GP. Athens: Hylonome Editions; 1998:121-147.
4. Hock JM, Gera I: Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. J Bone Miner Res 1992, 7:65-72.
5. Dobnig H, Turner RT: The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats. Endocrinology 1997, 138:4607-4612. First paper investigating exposure time to elevated PT levels as a critical determinant of bone anabolic or catabolic effects.
6. Ishizuya T, Yokose S, Hori M, Noda T, Suda T, Yoshiki S, Yamaguchi A: Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. J Clin Invest 1997, 99:2961-2970.
7. Armamento-Villareal R, Ziambaras K, Abbasi-Jarhomi SH, Dimarogonas A, Halstead L, Fausto A, et al.: An intact N terminus is required for the anabolic action of parathyroid hormone on adult female rats. J Bone Miner Res 1997, 12:384-392.
8. Gamse R, Gasser J, Seuwn K, Gombert OF, Feyen JHM: The N-terminus of human parathyroid hormone-(1-38) is essential for bone forming activity [abstract 107]. 3rd International Conference on New Actions of Parathyroid Hormone. Kyoto, Japan, April 18-21, 1994:91.
9. Hilliker S, Wergedal JE, Gruber HE, Bettica P, Baylink DJ: Truncation of the amino terminus of PTH alters its anabolic activity on bone in vivo. Bone 1996, 19:469-477.
10. Olstad OK, Reppe S, Loseth OP, Jemtland R, Gautvik KM: Binding and cyclic AMP stimulation by N-terminally deleted human PTHs (3-84 and 4-84) in a homologous ligand receptor system. J Bone Miner Res 1997, 12:1348-1357.
11. Whitfield JF, Morley P, Langille R, Willick G: Adenylyl cyclase-activating anabolic agents: parathyroid hormone and prostaglandin E. In Anabolic Treatments for Osteoporosis. Edited by Whitfield JF, Morley O. Boca Raton, FL: CRC Press: 1997:109-149.
12. Rixon RH, Whitfield JF, Gangon L, Isaacs RJ, Maclean S, Chakravarthy B, et al.: Parathyroid hormone fragments may stimulate bone growth in ovariectomized rats by activating adenylyl cyclase. J Bone Miner Res 1994, 9:1179-1189.
13. Whitfield JF, Morley P, Willick GE, Ross V, Barbier J-R, Isaacs RJ, Ohannessian-Barry L: Stimulation of the growth of femoral trabecular bone in ovariectomized rats by the novel parathyroid hormone fragment, hPTH(1-31)2 (ostabolin). Calcif Tissue Int 1996, 58:81-87.
14. 2 to stimulate bone growth in ovariectomized rats. J Bone Miner Res 1997, 12:1246-1252. Description of improved anabolic action of a PTH fragment that does not activate PLC activity.
15. Gamse R, Bauer W, Cardinaux F, Feyen JHM, Gasser JA, Gombert OF, Seuwen K: SDZ PTS 893: Pharmacological profile of a highly potent novel PTH analog [abstract]. J Bone Miner Res 1997, 12(suppl 1):S317.
16. Gasser JA, Gombert FO, Cardinaux F: SDZ PTS 893, a PTH-analog with improved therapeutic window in skeletally mature rats [abstract]. J Bone Miner Res 1997 12(suppl 1):S236.
17. Lindsay R, Nieves J, Formica C, Henneman E, Woelfert L, Shen V, et al.: Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis. Lancet 1997 350:550-555. First report on reduction in fracture rate in osteoporotic patients.
18. Reeve J, Meunier PJ, Parsons JA, Bernat M, Bijvoet OLM, Courpron P, et al.: Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. BMJ June 7, 1980:1340-1344.
19. Hesp R, Hulme P, Williams D, Reeve J: The relationship between changes in femoral bone density and calcium balance in patients with involutional osteoporosis treated with human parathyroid hormone fragment (hPTH 1-34). Metab Bone Dis Rel Res 2:331-334, 1981.
20. Neer R, Slovick DM, Daly M, Potts JT Jr, Nussbaum SR: Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol. Osteoporos Int 1998, 3(suppl 1): S204-S205.
21. Cosman F, Nieves J, Woelfert L, Gordon S, Shen V, Lindsay R: Parathyroid responsivity in postmenopausal women with osteoporosis during treatment with parathyroid hormone. J Clin Endocrinol Metab 1998, 83:788-790. Long-term safety with regard to the response of the parathyroid gland to hypocalcemic challenge after long-term administration of supraphysiologic doses of PTH.
22. Kotzmann H, Abela C, Heindl J, Clodi M, Riedl M, Barnas U, et al.: Effect of successful parathyroidectomy on hematopoietic progenitor cells and parameters of red blood cells in patients with primary hyperparathyroidism. Horm Metab Res 1997 29:387-392.
23. Whitfield JF, Morley P, Ross V, Preston E, Soska M, Barbier JR, et al.: The hypotensive actions of osteogenic and nonosteogenic parathyroid hormone fragments. Calcif Tissue Int 1997, 60:302-308.
24. Miller SC, Hunziker J, Mecham M, Wronski TJ: Intermittent parathyroid hormone administration stimulates bone formation in the mandibles of aged ovariectomized rats. J Dent Res 1997, 76:1471-1476. Potential usefulness of PTH in periodontal disease.
25. Chow JW, Fox S, Jagger CJ, Chambers TJ: Role for parathyroid hormone in mechanical responsiveness of rat bone. Am J Physiol 1998, 274(1 part 1):E146-154. Permissive role of PTH in mechanical responsiveness of bone. PTH as a modulator of the strain-sensing mechanism.
26. Gasser JA: Quantitative assessment of bone mass and geometry by pQCT in rats in vivo and site specificity of changes at different skeletal sites. J Jpn Soc Bone Morphom 1997, 7:107-114. Description of plateau effect and responsiveness of various skeletal sites.
27. Mosekilde L, Danielsen CC, Gasser JA: The effect on vertebral bone mass and strength of long-term treatment with antiresorptive agents (estrogen and calcitonin), human parathyroid hormone (1-38), and combination therapy, assessed in aged ovariectomised rats. Endocrinology 1994, 134:2126-2134.
28. Mosekilde L, Danielsen CC, Sogaard CH, McOsker JE, Wronski TJ: The anabolic effects of parathyroid hormone on cortical bone mass, dimensions and strength assessed in a sexually mature, ovariectomized rat model. Bone 1995, 16:223-230.
29. Civitelli R, Ziambaras K, Warlow PM, Lecanda F, Nelson T, Harley J, et al.: Regulation of connexin43 expression and function by prostaglandin E2 (PGE2) and parathyroid hormone PTH in osteoblastic cells. J Cell Biochem 1998, 68:8-21. Effect of PTH on intercellular communication in osteoblasts through upregulation of connexin 43.
30. Schiller PC, Roos BA, Howard GA: Parathyroid hormone up-regulation of connexin 43 gene expression in osteoblasts depends on cell phenotype. J Bone Miner Res 1997, 12:2005-2013. Effect of PTH on intercellular communication in osteoblasts through upregulation of connexin. 43
31. Fox J, Miller MA, Stroup GB, Nemeth EF, Miller SC: Plasma levels of parathyroid hormone that induce anabolic effects in bone of ovariectomized rats can be achieved by stimulation of endogenous hormone secretion. Bone 1997, 21:163-169. Release of endogenous PTH as a novel approach to the treatment of osteoporosis.
32. Selye H: On the stimulation of new bone formation with parathyroid extract, irradiated ergosteral. Endocrinology 1932, 16:547-558.